INSIGHTS ON DRUG DEVELOPMENT
-
5 Trends Impacting CMOs In 2025
In 2025, CMOs will navigate Annex 1 compliance, the BioSecure Act’s uncertainty, AI-driven drug development, supply chain challenges from tariffs, and pandemic preparedness strategies.
-
Navigating Preclinical Drug Development Challenges With Lipid-Based Formulations
Maximize the oral bioavailability of challenging small-molecule candidates and streamline the path from preclinical toxicology to clinical trials by leveraging optimized lipid-based formulations.
-
Matrigel Dome Assay And Drug Screening Of Colorectal Cancer Organoids
Using CRC organoids and bioprinting, explore the automation of dome assays to evaluate drug responses and delve into the insights from image-based end-point assays on the efficacy of anti-cancer treatments.
-
Expanding Opportunities For Inhaled Drug Delivery
Review the challenges and intricacies of effectively delivering drugs to the lung and the advantages of using nanoparticles and gentle particle processing techniques to enable delivery of sensitive drugs.
-
Streamlining pDNA: Capacity, Complexity, And Cutting-Edge Solutions11/20/2025
Learn how flexible facility design and process innovation are accelerating pDNA manufacturing, as well as key strategies to avoid scale-up pitfalls and meet growing therapeutic demand.
-
Working With Clients To Develop Manufacturing Processes7/23/2026
Greg Buenger, Group Leader of Chemical Development at Cambrex Charles City, on what it actually looks like when R&D hands a process to the plant — chemists on the floor for the first batch, advising operators and troubleshooting in real time.
-
Accelerating Clinical Development: Modern Tools In Process Chemistry1/23/2025
Whether you aim to address bottlenecks or explore advanced techniques, gain a practical and forward-thinking perspective to streamline early-phase development with HTE and model-based approaches.
-
Facilitate Handling Of Bulk Powders With Dry Granulation8/11/2025
Handling bulk powders in manufacturing presents serious challenges—from unpredictable caking to safety risks—that can disrupt workflows. Discover solutions to streamline operations and protect your team.
-
Assessing Production And Stability Of Antibody Drug Conjugate Platforms9/24/2025
ADCs with similar antibody sequences can behave differently due to linker and payload choices. Analytical tools reveal structural and stability differences critical to therapeutic performance.
DRUG DEVELOPMENT SOLUTIONS
-
Synthetic oligonucleotide therapeutics, such as antisense oligonucleotides (ASOs) and small interfering RNAs (si-RNAs), require thorough analysis to establish purity and quality.
-
Integrated drug discovery greatly benefits programs by blending various scientific disciplines into a unified team focused on your project.
-
Eurofins offers the world’s largest network of harmonized GMP bio/pharmaceutical testing labs, delivering comprehensive, compliant, and customizable CMC services across the drug development lifecycle.
-
Off-the-shelf, research use only lipid nanoparticle (LNP) reagents to deliver RNA into T-cells.
-
Integrated lab services deliver method development, validation, and testing across modalities, supporting quality, compliance, and formulation progress from early development to commercialization.